(Q39508627)

12 September 2017

title

Hydralazine-induced promoter demethylation enhances sarcoplasmic reticulum Ca2+ -ATPase and calcium homeostasis in cardiac myocytes (English)

1 reference

12 September 2017

Yu-Hsun Kao

1

1 reference

12 September 2017

Chen-Chuan Cheng

2

1 reference

12 September 2017

Yao-Chang Chen

3

1 reference

12 September 2017

Cheng-Chih Chung

4

1 reference

12 September 2017

Ting-I Lee

5

1 reference

12 September 2017

Shih-Ann Chen

6

1 reference

12 September 2017

Yi-Jen Chen

7

1 reference

12 September 2017

language of work or name

1 reference

11 July 2011

1 reference

12 September 2017

published in

Laboratory Investigation

1 reference

12 September 2017

volume

91

1 reference

12 September 2017

issue

9

1 reference

12 September 2017

page(s)

1291-1297

1 reference

https://scigraph.springernature.com/pub.10.1038/labinvest.2011.92

12 September 2017

exact match

0 references

cites work

The Ca2+ ATPase of cardiac sarcoplasmic reticulum: Physiological role and relevance to diseases

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.92

Lentiviral vector-mediated SERCA2 gene transfer protects against heart failure and left ventricular remodeling after myocardial infarction in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.92

Transgenic rat hearts overexpressing SERCA2a show improved contractility under baseline conditions and pressure overload

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.92

Tumor necrosis factor-alpha decreases sarcoplasmic reticulum Ca2+-ATPase expressions via the promoter methylation in cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.92

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.92

Isosorbide dinitrate and hydralazine in blacks with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.92

Effects of nitrates and hydralazine in heart failure: clinical evidence before the african american heart failure trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.92

The oxidative stress concept of nitrate tolerance and the antioxidant properties of hydralazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.92

Hydralazine prevents nitroglycerin tolerance by inhibiting activation of a membrane-bound NADH oxidase. A new action for an old drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.92

Comparison of biological effects of non-nucleoside DNA methylation inhibitors versus 5-aza-2'-deoxycytidine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.92

Molecular modeling and molecular dynamics studies of hydralazine with human DNA methyltransferase 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.92

Hydralazine target: from blood vessels to the epigenome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.92

Cardiac physiology at the cellular level: use of cultured HL-1 cardiomyocytes for studies of cardiac muscle cell structure and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.92

Development of heart failure following isoproterenol administration in the rat: role of the renin-angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.92

Effects of a Na+/Ca2+ exchanger inhibitor on pulmonary vein electrical activity and ouabain-induced arrhythmogenicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.92

SERCA2A overexpression decreases the incidence of aftercontractions in adult rabbit ventricular myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.92

S-Glutathiolation by peroxynitrite activates SERCA during arterial relaxation by nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.92

A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.92

A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.92

Alterations of Sarcoplasmic Reticulum Proteins in Failing Human Dilated Cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.92

7 January 2021

Decreased expression of cardiac sarcoplasmic reticulum Ca(2+)-pump ATPase in congestive heart failure due to myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.92

7 January 2021

Prevention of ventricular arrhythmias with sarcoplasmic reticulum Ca2+ ATPase pump overexpression in a porcine model of ischemia reperfusion

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.92

7 January 2021

Cytoplasmic Ca2+ does not inhibit the cardiac muscle sarcoplasmic reticulum ryanodine receptor Ca2+ channel, although Ca(2+)-induced Ca2+ inactivation of Ca2+ release is observed in native vesicles

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.92

7 January 2021

Evidence for calcineurin-mediated regulation of SERCA 2a activity in human myocardium

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.92

7 January 2021

Reversal of cardiac dysfunction after long-term expression of SERCA2a by gene transfer in a pre-clinical model of heart failure

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.92

7 January 2021

10.1038/LABINVEST.2011.92

Identifiers

DOI

1 reference

12 September 2017

1 reference